TY - JOUR A1 - Basset, Yves A1 - Cizek, Lukas A1 - Cuénoud, Philippe A1 - Didham, Raphael K. A1 - Novotny, Vojtech A1 - Ødegaard, Frode A1 - Roslin, Tomas A1 - Tishechkin, Alexey K. A1 - Schmidl, Jürgen A1 - Winchester, Neville N. A1 - Roubik, David W. A1 - Aberlenc, Henri-Pierre A1 - Bail, Johannes A1 - Barrios, Hector A1 - Bridle, Jonathan R. A1 - Castaño-Meneses, Gabriela A1 - Corbara, Bruno A1 - Curletti, Gianfranco A1 - da Rocha, Wesley Duarte A1 - De Bakker, Domir A1 - Delabie, Jacques H. C. A1 - Dejean, Alain A1 - Fagan, Laura L. A1 - Floren, Andreas A1 - Kitching, Roger L. A1 - Medianero, Enrique A1 - de Oliveira, Evandro Gama A1 - Orivel, Jerome A1 - Pollet, Marc A1 - Rapp, Mathieu A1 - Ribeiro, Servio P. A1 - Roisin, Yves A1 - Schmidt, Jesper B. A1 - Sørensen, Line A1 - Lewinsohn, Thomas M. A1 - Leponce, Maurice T1 - Arthropod Distribution in a Tropical Rainforest: Tackling a Four Dimensional Puzzle JF - PLoS ONE N2 - Quantifying the spatio-temporal distribution of arthropods in tropical rainforests represents a first step towards scrutinizing the global distribution of biodiversity on Earth. To date most studies have focused on narrow taxonomic groups or lack a design that allows partitioning of the components of diversity. Here, we consider an exceptionally large dataset (113,952 individuals representing 5,858 species), obtained from the San Lorenzo forest in Panama, where the phylogenetic breadth of arthropod taxa was surveyed using 14 protocols targeting the soil, litter, understory, lower and upper canopy habitats, replicated across seasons in 2003 and 2004. This dataset is used to explore the relative influence of horizontal, vertical and seasonal drivers of arthropod distribution in this forest. We considered arthropod abundance, observed and estimated species richness, additive decomposition of species richness, multiplicative partitioning of species diversity, variation in species composition, species turnover and guild structure as components of diversity. At the scale of our study (2km of distance, 40m in height and 400 days), the effects related to the vertical and seasonal dimensions were most important. Most adult arthropods were collected from the soil/litter or the upper canopy and species richness was highest in the canopy. We compared the distribution of arthropods and trees within our study system. Effects related to the seasonal dimension were stronger for arthropods than for trees. We conclude that: (1) models of beta diversity developed for tropical trees are unlikely to be applicable to tropical arthropods; (2) it is imperative that estimates of global biodiversity derived from mass collecting of arthropods in tropical rainforests embrace the strong vertical and seasonal partitioning observed here; and (3) given the high species turnover observed between seasons, global climate change may have severe consequences for rainforest arthropods. KW - trees KW - species richness KW - beta-diveristy KW - strategy KW - turnover KW - similarity KW - biodiversity KW - specialization KW - herbivorous insects KW - assemblages Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-136393 VL - 10 IS - 12 ER - TY - JOUR A1 - Fernandez-Robredo, P. A1 - Sancho, A. A1 - Johnen, S. A1 - Recalde, S. A1 - Gama, N. A1 - Thumann, G. A1 - Groll, J. A1 - Garcia-Layana, A. T1 - Current Treatment Limitations in Age-Related Macular Degeneration and Future Approaches Based on Cell Therapy and Tissue Engineering JF - Journal of Ophtamology N2 - Age-related macular degeneration (AMD) is the leading cause of blindness in the Western world. With an ageing population, it is anticipated that the number of AMD cases will increase dramatically, making a solution to this debilitating disease an urgent requirement for the socioeconomic future of the European Union and worldwide. The present paper reviews the limitations of the current therapies as well as the socioeconomic impact of the AMD. There is currently no cure available for AMD, and even palliative treatments are rare. Treatment options show several side effects, are of high cost, and only treat the consequence, not the cause of the pathology. For that reason, many options involving cell therapy mainly based on retinal and iris pigment epithelium cells as well as stem cells are being tested. Moreover, tissue engineering strategies to design and manufacture scaffolds to mimic Bruch's membrane are very diverse and under investigation. Both alternative therapies are aimed to prevent and/or cure AMD and are reviewed herein. KW - endothelial growth factor KW - pluripotent stem cells KW - subfoveal choroidal neovascularization KW - human bruchs membrane KW - ciliary neurotrophic factor KW - randomized clinical trial KW - dystrophic RCS rats KW - subretinal space KW - in-vitro KW - retinal pigment epithelium Y1 - 2014 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-118004 SN - 2090-0058 IS - 510285 ER -